Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07055217 · ClinicalTrials.gov registry record · NA
Effect of Mindfulness-based Neurofeedback for Adolescents With Elevated Repetitive Negative Thinking
A NA study of Neurofeedback and Repetitive Negative Thinking, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07055217 is a NA study of Neurofeedback and Repetitive Negative Thinking that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07055217, a NA study of Neurofeedback and Repetitive Negative Thinking, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the hypotheses that adolescent with repetitive negative thinking who at at-risk for serious mental illness will show greater default mode network (DMN) connectivity than healthy controls, at-risk adolescents will show greater changes in DMN connectivity than healthy controls, and that a longer session of mindfulness based neurofeedback will lead to greater reduction in DMN connectivity. To do so, 50 adolescents with elevated repetitive negative thinking and 50 matched healthy control participants will be enrolled into a double-blind randomized clinical trial of a session of mindfulness training with either active mindfulness-basde neurofeedback or sham mindfulness-based neurofeedback.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness Training
- BEHAVIORAL Mindfulness-based Neurofeedback (Real mbNF)
- BEHAVIORAL Sham mindfulness-based neurofeedback (Sham mbNF)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital, Center for Addiction Medicine, 101 Merrimac Street, Suite 320, Boston, MA 02114 - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-11-04 |
| Est. Completion | 2027-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07055217
The ClinicalTrials.gov registry entry for NCT07055217 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Neurofeedback appearing as the primary indexed condition, and to 3 interventions - of which Mindfulness Training is the first listed.
NCT07055217 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07055217 about?
NCT07055217 is a clinical study titled "Effect of Mindfulness-based Neurofeedback for Adolescents With Elevated Repetitive Negative Thinking". This study will test the hypotheses that adolescent with repetitive negative thinking who at at-risk for serious mental illness will show greater default mode network (DMN) connectivity than healthy controls, at-risk adolescents will show greater changes in DMN connectivity than healthy controls, an...
What is the current status of trial NCT07055217?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-11-04. Estimated completion is 2027-04.
What conditions does trial NCT07055217 study?
This clinical trial studies the following conditions: Neurofeedback, Repetitive Negative Thinking.
What interventions are being tested in trial NCT07055217?
The interventions under investigation include: Mindfulness Training (BEHAVIORAL), Mindfulness-based Neurofeedback (Real mbNF) (BEHAVIORAL), Sham mindfulness-based neurofeedback (Sham mbNF) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07055217?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07055217 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurofeedback
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.